Axtria Unveils Agentic AI Platform for Life Sciences
Axtria has announced the launch of its new AI platform, Axtria InsightsMAx.ai, designed to revolutionize the life sciences sector. In a press release, the company detailed how the platform offers a flexible, enterprise-grade framework that includes over 30 ready-to-deploy agents, apps, and APIs. This infrastructure aims to accelerate AI experimentation, deployment, and return on investment for life sciences companies.
The platform addresses the 'last mile' problem in enterprise AI by providing a comprehensive ecosystem for successful adoption. It features a library of specialized agents that facilitate cross-functional transformation, breaking down silos between data analysis, business intelligence, and clinical development.
Axtria InsightsMAx.ai allows life sciences companies to start small with AI innovations and scale them across their organizations without needing to rebuild infrastructure. This capability significantly reduces the time from concept to deployment, potentially compressing it from years to mere weeks.
The platform is already in use by six of the top ten global pharmaceutical companies, delivering significant improvements in decision accuracy, speed to insights, and operational cost reductions.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Quotient Sciences and Acesion Apply AI to Atrial Fibrillation Drugs
Beyond Now Launches Agentic Revenue Platform for Communications Providers
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Teragonia Launches Astra Labs for Enterprise AI Workflows
Domino Data Lab and EPAM Partner on Validated AI for Life Sciences
Daily AI Brief: the AI news that matters, in your inbox.